Literature DB >> 29317152

Predicting long-term outcomes after cardiac arrest by using serum neutrophil gelatinase-associated lipocalin.

Yu-Ri Park1, Joo Suk Oh2, Hyunho Jeong3, Jungtaek Park4, Young Min Oh5, Semin Choi6, Kyoung Ho Choi7.   

Abstract

OBJECTIVES: Neutrophil gelatinase-associated lipocalin (NGAL) is secreted by various tissues in pathologic states. Previous studies reported that post-cardiac arrest serum NGAL levels correlate with short-term neurologic outcomes and survival. The aim of this study was to examine the associations between NGAL levels post-cardiac arrest and long-term outcomes and survival.
METHODS: This prospective observational study and retrospective review included adult out-of-hospital cardiac arrest survivors who were treated by hypothermia-targeted temperature management. Serum NGAL was assessed at 0, 24, 48, and 72h after return of spontaneous circulation. The primary outcome was poor outcome at six months after cardiac arrest, defined as cerebral performance category score of 3-5. The secondary outcome was six-month mortality.
RESULTS: In total, 76 patients were analyzed. The patients with poor outcomes showed significantly higher NGAL levels at 24, 48 and 72h after cardiac arrest than the patients with good outcomes. Long-term survival rates were significantly lower in the high-NGAL group than in the low-NGAL group at each time point. Subgroup analysis of patients who survived 72h showed that only serum NGAL 72h after cardiac arrest had prognostic value for long-term outcomes (area under the receiver operating characteristic curve=0.72; p=0.02).
CONCLUSIONS: Post-cardiac arrest serum NGAL is associated with long-term outcomes and survival; particularly, three days post-cardiac arrest is the optimal time point for predicting long-term outcomes. However, the predictive power of NGAL is unsatisfactory, and it should be regarded as an additional prognostic modality.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart arrest; Induced hypothermia; Lipocalin; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 29317152     DOI: 10.1016/j.ajem.2017.12.013

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Characterization of neutrophil-neuronal co-cultures to investigate mechanisms of post-ischemic immune-mediated neurotoxicity.

Authors:  Nguyen Mai; Viollandi Prifti; Minsoo Kim; Marc W Halterman
Journal:  J Neurosci Methods       Date:  2020-05-20       Impact factor: 2.390

2.  The identification of neutrophils-mediated mechanisms and potential therapeutic targets for the management of sepsis-induced acute immunosuppression using bioinformatics.

Authors:  Fang Chen; Chunyan Yao; Yue Feng; Ying Yu; Honggang Guo; Jing Yan; Jin Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

3.  Comparison of different clinical risk scores to predict long-term survival and neurological outcome in adults after cardiac arrest: results from a prospective cohort study.

Authors:  René Blatter; Simon A Amacher; Chantal Bohren; Christoph Becker; Katharina Beck; Sebastian Gross; Kai Tisljar; Raoul Sutter; Stephan Marsch; Sabina Hunziker
Journal:  Ann Intensive Care       Date:  2022-08-17       Impact factor: 10.318

4.  The title: serum neutrophil Gelatinase-associated Lipocalin at 3 hours after return of spontaneous circulation in patients with cardiac arrest and therapeutic hypothermia: early predictor of acute kidney injury.

Authors:  Yoon Hee Choi; Dong Hoon Lee; Jae Hee Lee
Journal:  BMC Nephrol       Date:  2020-09-07       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.